Sam-A Pharm Dividends and Buybacks
Dividend criteria checks 4/6
Sam-A Pharm is a dividend paying company with a current yield of 5% that is well covered by earnings. Next payment date is on 27th April, 2026 with an ex-dividend date of 29th December, 2025.
Key information
5.0%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | n/a |
| Dividend Growth | 22.0% |
| Next dividend pay date | 27 Apr 26 |
| Ex dividend date | 29 Dec 25 |
| Dividend per share | n/a |
| Payout ratio | 37% |
Recent dividend and buyback updates
Recent updates
We Think That There Are More Issues For Sam-A Pharm (KOSDAQ:009300) Than Just Sluggish Earnings
Apr 01
Take Care Before Jumping Onto Sam-A Pharm. Co., Ltd (KOSDAQ:009300) Even Though It's 26% Cheaper
Dec 06Should You Be Adding Sam-A Pharm (KOSDAQ:009300) To Your Watchlist Today?
Nov 13Earnings Working Against Sam-A Pharm. Co., Ltd's (KOSDAQ:009300) Share Price Following 34% Dive
Aug 25Sam-A Pharm. Co., Ltd's (KOSDAQ:009300) Price Is Right But Growth Is Lacking After Shares Rocket 32%
Jul 11Should You Be Adding Sam-A Pharm (KOSDAQ:009300) To Your Watchlist Today?
Jun 21Sam-A Pharm. Co., Ltd's (KOSDAQ:009300) Shares Bounce 26% But Its Business Still Trails The Market
May 25Key Things To Consider Before Buying Sam-A Pharm. Co., Ltd (KOSDAQ:009300) For Its Dividend
Apr 08Is Sam-A Pharm (KOSDAQ:009300) A Risky Investment?
Mar 04How Much Did Sam-A Pharm's(KOSDAQ:009300) Shareholders Earn From Share Price Movements Over The Last Three Years?
Jan 28
Four Days Left To Buy Sam-A Pharm. Co., Ltd (KOSDAQ:009300) Before The Ex-Dividend Date
Dec 24Sam-A Pharm. Co., Ltd (KOSDAQ:009300) Is Yielding 1.6% - But Is It A Buy?
Dec 07Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, A009300 has been paying a dividend for less than 10 years.
Growing Dividend: A009300's dividend payments have increased, but the company has only paid a dividend for 6 years.
Dividend Yield vs Market
| Sam-A Pharm Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A009300) | 5.0% |
| Market Bottom 25% (KR) | 1.0% |
| Market Top 25% (KR) | 3.6% |
| Industry Average (Pharmaceuticals) | 0.7% |
| Analyst forecast (A009300) (up to 3 years) | n/a |
Notable Dividend: A009300's dividend (5%) is higher than the bottom 25% of dividend payers in the KR market (0.99%).
High Dividend: A009300's dividend (5%) is in the top 25% of dividend payers in the KR market (3.61%)
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (37%), A009300's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (54.3%), A009300's dividend payments are covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/14 10:04 |
| End of Day Share Price | 2026/04/14 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sam-A Pharm. Co., Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.